National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 367192

Government Disclaimer on use of this data

Case Details

VAERS ID: 367192 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 2009-11-13
   Days after onset:57
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Cyanosis, Dizziness, Hypoventilation, Immediate post-injection reaction, Syncope, Unresponsive to stimuli
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow), Respiratory failure (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PARACETAMOL
Current Illness: Unknown
Preexisting Conditions: PANIC ATTACK
Diagnostic Lab Data: UNK
CDC Split Type: B0602195A

Write-up: This case was reported by the foreign regulatory authority (Regulatory Agency #20518357) and described the occurrence of fainting in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included panic attacks. Concurrent medications included PARACETAMOL. On 17 September 2009 the subject received the first dose of CERVARIX (intramuscular, batch: AHPV043BB09/2). On 17 September 2009, immediately after vaccination with CERVARIX, the subject felt faint. This spontaneously resolved, however, the subject stopped responding again. On an unknown date, the subject experienced shallow breathing, cyanotic lips & nose and was unresponsive to verbal stimuli. The subject was treated with adrenaline at 0.5 mg and started to respond. The regulatory authority reported that the subject was hospitalised. At the time of reporting the events were improved. Patient felt faint immediately after immunisation then spontaneous recovery, then stopped responding again. Patient experienced shallow breathing, cyanosis lips and nose. After adrenaline 0.5 mg was given the patient started responding. The patient then was transferred to hospital. This was the patients first dose of vaccine.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166